Privium Fund Management B.V. Wave Life Sciences Ltd. Transaction History
Privium Fund Management B.V.
- $469 Million
- Q2 2025
A detailed history of Privium Fund Management B.V. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Privium Fund Management B.V. holds 135,550 shares of WVE stock, worth $1.1 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
135,550
Previous 113,550
19.37%
Holding current value
$1.1 Million
Previous $917,000
3.93%
% of portfolio
0.19%
Previous 0.24%
Shares
4 transactions
Others Institutions Holding WVE
# of Institutions
202Shares Held
125MCall Options Held
499KPut Options Held
180K-
Ra Capital Management, L.P. Boston, MA18.2MShares$148 Million3.05% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA12.5MShares$102 Million0.2% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$67.2 Million1.31% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$54.8 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.36MShares$51.7 Million0.56% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $706M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...